3/12
01:21 pm
mgnx
MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/10
04:22 pm
mgnx
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
3/10
11:02 am
mgnx
MacroGenics (MGNX) had its price target raised by Barclays PLC from $3.00 to $4.00. They now have an "overweight" rating on the stock.
High
Report
MacroGenics (MGNX) had its price target raised by Barclays PLC from $3.00 to $4.00. They now have an "overweight" rating on the stock.
3/9
04:42 pm
mgnx
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures [Yahoo! Finance]
High
Report
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures [Yahoo! Finance]
3/9
04:01 pm
mgnx
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
High
Report
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
2/26
05:30 pm
mgnx
MacroGenics to Participate in Upcoming Investor Conferences
Neutral
Report
MacroGenics to Participate in Upcoming Investor Conferences
2/24
07:01 am
mgnx
MacroGenics (NASDAQ:MGNX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
High
Report
MacroGenics (NASDAQ:MGNX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
2/23
06:14 pm
mgnx
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Low
Report
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
1/9
08:13 am
mgnx
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer [Yahoo! Finance]
Neutral
Report
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer [Yahoo! Finance]
1/3
05:42 am
mgnx
MacroGenics (NASDAQ:MGNX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
MacroGenics (NASDAQ:MGNX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.